Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Nguyen, Nhung T H ^a   Now, Hesung ^a   Kim, Woo Jong ^a   Kim, Nari ^a   Yoo, Joo Yeon ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DDX58 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; IRF3 PROTEIN, HUMAN; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSCRIPTION FACTOR; TRIM25 PROTEIN, HUMAN; TRIPARTITE MOTIF PROTEIN; UBD PROTEIN, HUMAN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

HEK293 CELL LINE; HUMAN; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY;

DEAD BOX PROTEIN 58; HEK293 CELLS; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRIPARTITE MOTIF PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 84961784072     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23377     Document Type: Article

References (50)

1. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
2. West, A. P., Shadel, G. S., Ghosh, S. Mitochondria in innate immune responses. Nature reviews. Immunol. 11, 389-402 (2011).
3. Seth, R. B., Sun, L., Ea, C. K., Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-682 (2005).
4. Loo, Y. M., Gale, M. Jr. Immune signaling by RIG-I-like receptors. Immunity 34, 680-692 (2011).
5. Trinchieri, G. Type I interferon: friend or foe? J. Exp. Med. 207, 2053-2063 (2010).
6. Tisoncik, J. R. et al. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76, 16-32 (2012).
7. Jang, M. A. et al. Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am. J. Hum. Genet. 96, 266-274 (2015).
8. Suarez-Calvet, X. et al. Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis. J. Pathol. 233, 258-268 (2014).
9. Maelfait, J., Beyaert, R. Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol. Mol. Biol. Rev. 76, 33-45 (2012).
10. Zou, W., Zhang, D. E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281, 3989-3994 (2006).
11. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
12. Mi, Z., Fu, J., Xiong, Y., Tang, H. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein & cell 1, 275-283, doi: 10.1007/s13238-010-0030-1 (2010).
13. Jounai, N. et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl. Acad. Sci. USA. 104, 14050-14055 (2007).
14. Kim, M. J., Hwang, S. Y., Imaizumi, T., Yoo, J. Y. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferoninduced ISG15 conjugation. J. Virol. 82, 1474-1483 (2008).
15. Hipp, M. S., Kalveram, B., Raasi, S., Groettrup, M., Schmidtke, G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 25, 3483-3491 (2005).
16. Liu, Y. C. et al. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc. Natl. Acad. Sci. USA. 96, 4313-4318 (1999).
17. Ren, J., Wang, Y., Gao, Y., Mehta, S. B., Lee, C. G. FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability. J. Cell. Sci. 124, 3665-3675 (2011).
18. Kalveram, B., Schmidtke, G., Groettrup, M. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J. Cell. Sci. 121, 4079-4088 (2008).
19. Lee, C. G. et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22, 2592-2603 (2003).
20. Lukasiak, S. et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 27, 6068-6074 (2008).
21. Choi, Y., Kim, J. K., Yoo, J. Y. NFkappaB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53. Mol. Oncol. 8, 642-655 (2014).
22. Liu, L. et al. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3beta pathway. Oncogene 33, 909-920 (2014).
23. Yuan, R. et al. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying betacatenin degradation. Cancer Res. 74, 5287-5300 (2014).
24. Onomoto, K. et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PloS one 7, e43031, doi: 10.1371/journal.pone.0043031 (2012).
25. Ng, C. S. et al. Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J. Virol. 87, 9511-9522 (2013).
26. Aichem, A. et al. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation. J. Cell. Sci. 125, 4576-4585 (2012).
27. Buchsbaum, S., Bercovich, B., Ciechanover, A. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination. Mol. Biol. Cell. 23, 225-232 (2012).
28. Gack, M. U. et al. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. USA 105, 16743-16748 (2008).
29. Zhang, P. et al. TRIM25 has a dual function in the p53/Mdm2 circuit. Oncogene, doi: 10.1038/onc.2015.21 (2015).
30. Allen, I. C. et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways. Immunity 34, 854-865 (2011).
31. Peng, Y., Xu, R., Zheng, X. HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1. PLoS Pathog. 10, e1004041, doi: 10.1371/journal.ppat.1004041 (2014).
32. Cui, J. et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell. 141, 483-496 (2010).
33. Solis, M. et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J. Virol. 85, 1224-1236 (2011).
34. Santiago, F. W. et al. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J. Virol. 88, 4572-4585 (2014).
35. Hong, Y. K. et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 36, 683-685 (2004).
36. Snyder, A. et al. FAT10: a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy. J. Virol. 83, 11983-11988, (2009).
37. Spinnenhirn, V. et al. The ubiquitin-like modifier FAT10 decorates autophagy-targeted Salmonella and contributes to Salmonella resistance in mice. J. Cell. Sci. 127, 4883-4893 (2014).
38. Canaan, A. et al. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol. Cell. Biol. 26, 5180-5189 (2006).
39. Buerger, S. et al. The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell Selection. J. Immunol. 195, 4106-4116 (2015).
40. Nagashima, Y., Kowa, H., Tsuji, S., Iwata, A. FAT10 protein binds to polyglutamine proteins and modulates their solubility. J. Biol. Chem. 286, 29594-29600 (2011).
41. Buchsbaum, S., Bercovich, B., Ziv, T., Ciechanover, A. Modification of the inflammatory mediator LRRFIP2 by the ubiquitin-like protein FAT10 inhibits its activity during cellular response to LPS. Biochem. Biophys. Res. Commun. 428, 11-16 (2012).
42. Mukherjee, A. et al. Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions. J. Biol.Chem. 284, 6486-6494 (2009).
43. Legrand-Poels, S. et al. Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton. J. Cell. Sci. 120, 1299-1310 (2007).
44. Goedert, M. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. Curr. Opin. Genet. Dev. 11, 343-351 (2001).
45. Balajee, A. S., Geard, C. R. Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells. Nucleic Acid. Res. 29, 1341-1351 (2001).
46. Tuoc, T. C., Stoykova, A. Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system. Genes. Dev. 22, 1972-1986 (2008).
47. Muchowski, P. J., Wacker, J. L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci 6, 11-22 (2005).
48. Urano, T. et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417, 871-875 (2002).
49. Kim, M. J., Yoo, J. Y. Active caspase-1-mediated secretion of retinoic acid inducible gene-I. J. Immunol. 181, 7324-7331 (2008).
50. Hwang, S. Y. et al. 5?-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity. Nucleic Acids. Res. 40, 2724-2733, doi: 10.1093/nar/gkr1098 (2012).